Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/06/2003WO2002081644A3 Haplotyping method for multiple distal nucleotide polymorphisms
03/06/2003WO2002080755A9 Kits and methods for assessing oxidative stress
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002070651A3 Viral reporter particles
03/06/2003WO2002067868A3 Methods for the treatment of metabolic disorders, including obesity and diabetes
03/06/2003WO2002065515A3 Nanostructured devices for separation and analysis
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064092A3 Method for evaluating therapeutic efficacy
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002059262A3 Compositions and methods for detecting proteolytic activity
03/06/2003WO2002053579A3 Haplotypes of the fmo2 gene
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002046483A3 Silver stain removal from dna detection chips by cyanide etching or sonication
03/06/2003WO2002045835A3 Microelectronic arrays for cell-based functional genomics / high throughput phenotyping by electrokinetic assembly
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002027027A3 Method of screening for therapeutics for infectious diseases
03/06/2003WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/06/2003WO2002024956A8 Genetic markers for tumors
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002020735A3 Enzymes having high temperature polymerase activity and methods of use thereof
03/06/2003WO2002018636A3 Improvements in and relating to marking using dna
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002010401A3 18431 and 32374, human protein kinase family members and uses therefor
03/06/2003WO2002006522A3 Estrogen receptor gene polymorphisms as markers for determining a predisposition for low bone density
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2002002796A3 Disposable electrochemical bio-sensor for the quantitative determination of analyte concentrations in fluids
03/06/2003WO2002001228A8 Interaction of colloid-immobilized species with species on non-colloidal structures
03/06/2003WO2002000336A3 Composite arrays utilizing microspheres with a hybridization chamber
03/06/2003WO2001096540A3 Hepatitis c protease exosite for inhibitor design
03/06/2003WO2001092525A8 Compositions and methods for the therapy and diagnosis of lung cancer
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001090313A9 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001083825A3 Colloid compositions for solid phase biomolecular analytical systems
03/06/2003WO2001074900A9 Nuclear factor kb inducing factor
03/06/2003WO2001073124A9 Rapid response glucose sensor
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001062924A9 Human g protein-coupled receptors
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030046724 Crossing recipient parent with donor parent to produce F1 hybrid plant, transforming cell of F1 hybrid plant with transferred DNA, finding transformed F1 hybrid cell containing transferred DNA, using flanking DNA to identify parent
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030045746 Phosphorous organic compounds and their use
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045695 Ribozyme for detecting gene sequence
03/06/2003US20030045694 Ultra-sensitive detection systems
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045529 Method for specifically potentiating N-type Ca2+ channel activity
03/06/2003US20030045491 Identification of cancerous cells and identifying antitumor drugs by detection of expression levels of tyrosine threonine kinase; inhibiting tumor growth (especially breast and colon cancer)by inhibiting activity of TTK
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045456 Complex comprising OCIF and polysaccharide
03/06/2003US20030045451 Determining or predicting response to cancer therapy in an individual using differential image analysis of immunohistochemically stained tumor samples.
03/06/2003US20030045005 Light-controlled electrokinetic assembly of particles near surfaces
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044968 Capillary array-based sample screening
03/06/2003US20030044961 Compositions for transferring active compounds in a cell-specific manner
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044905 Nucleic acids, proteins, and antibodies
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044895 Nucleotide sequences coding polypeptide for use in t he treatment of tumors, respiratory and liver disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044890 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's disease and brain disorders
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044883 Method of screening candidate compounds for susceptibility to biliary excretion
03/06/2003US20030044882 Composition for use in the detection and classification of microorganism in sample
03/06/2003US20030044877 Novel enzymatic substrates for detecting pseudomonas aeruginosa, compositions containing same and method for detecting said species
03/06/2003US20030044876 Detection of proteases in bodily fluids; obtain fluid sample, incubate with chromogenic substrate, detect indicator adjustment, adjustment indicates protease
03/06/2003US20030044875 Substrate for PP2C
03/06/2003US20030044874 Detection of preferential particles in sample; obtain test strip, expose to dialysate, determine glucose concentration
03/06/2003US20030044873 Apparatus for monitoring bicarbonate concentration
03/06/2003US20030044871 Kit for use in monitoring blood coagulation
03/06/2003US20030044866 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044861 Method for diagnosing neoplasia
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044855 Microarrays and their manufacture by slicing
03/06/2003US20030044852 Detecting modulator of diabetic defects; obtain cells, incubate with modulator, monitor cell response to modulator, evaluate for insulin resistance
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044836 Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays
03/06/2003US20030044835 Generating solid support associated with metal surface; obtain thin layer, deposit on metal surface in preferential pattern, react layer with metal surface, attach biopolymer or cells to microarray
03/06/2003US20030044831 Antibody for use in the generation and protection of preferential nucleotide sequences
03/06/2003US20030044830 Method of reducing background in florescence detection
03/06/2003US20030044829 Methods for detecting and monitoring COX-2 RNA in plasma and serum